Garcia-Pagan JC - Search Results

1

Porto-sinusoidal vascular disease: proposal and description of a novel entity.

De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC; VALDIG group. De Gottardi A, et al. Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0. Lancet Gastroenterol Hepatol. 2019. PMID: 30957754

2

Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.

García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J. García-Pagán JC, et al. J Hepatol. 1996 Apr;24(4):430-5. doi: 10.1016/s0168-8278(96)80163-2. J Hepatol. 1996. PMID: 8738729 Clinical Trial.

3

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodés J. Bruix J, et al. Gastroenterology. 1996 Oct;111(4):1018-22. doi: 10.1016/s0016-5085(96)70070-7. Gastroenterology. 1996. PMID: 8831597

4

Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.

García-Pagàn JC, Santos C, Barberá JA, Luca A, Roca J, Rodriguez-Roisin R, Bosch J, Rodés J. García-Pagàn JC, et al. Gastroenterology. 1996 Nov;111(5):1300-6. doi: 10.1053/gast.1996.v111.pm8898644. Gastroenterology. 1996. PMID: 8898644

5

Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.

Andreu V, Perello A, Moitinho E, Escorsell A, García-Pagán JC, Bosch J, Rodés J. Andreu V, et al. J Hepatol. 2002 Mar;36(3):356-61. doi: 10.1016/s0168-8278(01)00300-2. J Hepatol. 2002. PMID: 11867179 Clinical Trial.

6

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Fernandez M, et al. Gastroenterology. 2004 Mar;126(3):886-94. doi: 10.1053/j.gastro.2003.12.012. Gastroenterology. 2004. PMID: 14988842

7

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J. Fernandez M, et al. J Hepatol. 2005 Jul;43(1):98-103. doi: 10.1016/j.jhep.2005.02.022. Epub 2005 Apr 25. J Hepatol. 2005. PMID: 15893841

8

Utility of color Doppler ultrasonography predicting tips dysfunction.

Abraldes JG, Gilabert R, Turnes J, Nicolau C, Berzigotti A, Aponte J, Bru C, Bosch J, García-Pagán JC. Abraldes JG, et al. Am J Gastroenterol. 2005 Dec;100(12):2696-701. doi: 10.1111/j.1572-0241.2005.00290.x. Am J Gastroenterol. 2005. PMID: 16393222

9

Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension.

Andreu V, Garcia-Pagan JC, Lionetti R, Piera C, Abraldes JG, Bosch J. Andreu V, et al. J Hepatol. 2006 Jun;44(6):1040-5. doi: 10.1016/j.jhep.2005.10.024. Epub 2005 Dec 6. J Hepatol. 2006. PMID: 16581151

10

Measurement of portal pressure and its role in the management of chronic liver disease.

Bosch J, Garcia-Pagán JC, Berzigotti A, Abraldes JG. Bosch J, et al. Semin Liver Dis. 2006 Nov;26(4):348-62. doi: 10.1055/s-2006-951603. Semin Liver Dis. 2006. PMID: 17051449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

479 results

Search Page

Filters